Discontinuation report ADLYXINE
| Report ID | 192514 |
| Drug Identification Number | 02464276 |
| Brand name | ADLYXINE |
| Common or Proper name | ADLYXINE |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | LIXISENATIDE |
| Strength(s) | 10MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 |
| ATC code | A10BJ |
| ATC description | |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-05-15 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Company business decision |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2023-05-16 | English | Compare |
| v2 | 2023-05-15 | French | Compare |
| v1 | 2023-05-15 | English | Compare |
Showing 1 to 3 of 3